Adam is a Principal at Truehelm. He serves as a leader on Truehelm’s investment team and is focused on sourcing and leading investments in high-growth healthcare services and healthcare information technology companies. Adam joined Truehelm in 2013 as an associate. After spending three years in that role, Truehelm supported Adam’s pursuit of an M.B.A. and he subsequently re-joined the firm in 2017.

He currently serves as a board director for Truehelm’s portfolio companies Pyx Health, Propio, and MedZed, and was previously on the board of Revel Health, Navigating Cancer, and NextHealth Technologies.

Adam has over a decade of healthcare investing and transaction experience and is passionate about partnering with management teams of innovative healthcare companies. He began his career in healthcare investment banking at Piper Sandler (then Piper Jaffray), and later worked in equity research covering financial and business services companies.

Adam holds a B.S.B. from the Carlson School of Management at the University of Minnesota with a major in Finance and an M.B.A. with Distinction from the Kellogg School of Management at Northwestern University.